Diaphorina citri psyllid: psy13769


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-----
MHLPSSKSPEMSSSIEAMTSDMFAGIHEALQEYHGELVQTGSPTILCSVLPTHWRSNKSLPIAFKVVVLDDVMDGTIVTIRAGNDDNYCGELRNCTAVVKNQVAKFNDLRFVGRSGRGKSFTLSIMVGSSPHQIASYNKAIKVTVDGPREPRSKS
cccccccccccccHHHHHcHHHHHHHHHHHHHccccccccccccEEECccccccccccccccccEEEEEEcccccEEEEEEEccccccCECccHHHHHHHccccccccCEECcccccccccEEEEEECccccHHHHHHcEEEEECcccccccccc
*********************MFAGIHEALQEYHGELVQTGSPTILCSVLPTHWRSNKSLPIAFKVVVLDDVMDGTIVTIRAGNDDNYCGELRNCTAVVKNQVAKFNDLRFVGRSGRGKSFTLSIMVGSSPHQIASYNKAIKVT***********
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MHLPSSKSPEMSSSIEAMTSDMFAGIHEALQEYHGELVQTGSPTILCSVLPTHWRSNKSLPIAFKVVVLDDVMDGTIVTIRAGNDDNYCGELRNCTAVVKNQVAKFNDLRFVGRSGRGKSFTLSIMVGSSPHQIASYNKAIKVTVDGPREPRSKS

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Runt-related transcription factor 1 CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Inhibits KAT6B-dependent transcriptional activation.confidentQ63046
Runt-related transcription factor 1 CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. Essential for the development of normal hematopoiesis. Isoform 4 shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter. Inhibits KAT6B-dependent transcriptional activation.confidentQ03347
Segmentation protein Runt Plays a pivotal role in regulating the expression of other pair-rule genes such as eve, ftz, and h.confidentP22814

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0000975 [MF]regulatory region DNA bindingconfidentGO:0097159, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0043565 [MF]sequence-specific DNA bindingconfidentGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0006357 [BP]regulation of transcription from RNA polymerase II promoterconfidentGO:0009889, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0010468
GO:0005634 [CC]nucleusconfidentGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0009987 [BP]cellular processconfidentGO:0008150
GO:0000977 [MF]RNA polymerase II regulatory region sequence-specific DNA bindingprobableGO:0043565, GO:0044212, GO:0001067, GO:0003677, GO:0001012, GO:0000976, GO:0005488, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0005509 [MF]calcium ion bindingprobableGO:0043169, GO:0046872, GO:0003674, GO:0005488, GO:0043167
GO:0006468 [BP]protein phosphorylationprobableGO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0005737 [CC]cytoplasmprobableGO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0000790 [CC]nuclear chromatinprobableGO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0032526 [BP]response to retinoic acidprobableGO:1901700, GO:0033993, GO:0050896, GO:0008150, GO:0042221, GO:0010033
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0042789 [BP]mRNA transcription from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0009299, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0005604 [CC]basement membraneprobableGO:0005578, GO:0031012, GO:0005575, GO:0005576, GO:0044420, GO:0044421
GO:0048469 [BP]cell maturationprobableGO:0032502, GO:0048856, GO:0048869, GO:0030154, GO:0048468, GO:0044767, GO:0044763, GO:0008150, GO:0009987, GO:0010259, GO:0044699
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0032609 [BP]interferon-gamma productionprobableGO:0001816, GO:0032501, GO:0008150, GO:0044699, GO:0044707
GO:0031069 [BP]hair follicle morphogenesisprobableGO:0032502, GO:0048513, GO:0009887, GO:0008544, GO:0044707, GO:0032501, GO:0001942, GO:0048856, GO:0009888, GO:0044767, GO:0042633, GO:0022404, GO:0022405, GO:0008150, GO:0048729, GO:0048730, GO:0048731, GO:0009653, GO:0042303, GO:0007275, GO:0044699
GO:0000981 [MF]sequence-specific DNA binding RNA polymerase II transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071
GO:0007411 [BP]axon guidanceprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0030099 [BP]myeloid cell differentiationprobableGO:0032502, GO:0002376, GO:0009987, GO:0044707, GO:0048856, GO:0048869, GO:0032501, GO:0030154, GO:0044767, GO:0048513, GO:0044763, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0048266 [BP]behavioral response to painprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0007610, GO:0006950, GO:0008150, GO:0033555, GO:0044699, GO:0048265
GO:0030853 [BP]negative regulation of granulocyte differentiationprobableGO:0002761, GO:0051093, GO:0002762, GO:0045596, GO:0050793, GO:0050789, GO:1902105, GO:0050794, GO:0030852, GO:1902106, GO:0045638, GO:0065007, GO:0002682, GO:0008150, GO:0051239, GO:0048519, GO:2000026, GO:0045595, GO:0045637, GO:0048523
GO:0030854 [BP]positive regulation of granulocyte differentiationprobableGO:0002761, GO:1902107, GO:0002763, GO:0051094, GO:0050793, GO:0065007, GO:0045597, GO:0045595, GO:0050794, GO:0030852, GO:0050789, GO:1902105, GO:0045639, GO:0002682, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0045637, GO:0048522
GO:0035170 [BP]lymph gland crystal cell differentiationprobableGO:0035168, GO:0048569, GO:0035167, GO:0035166, GO:0009791, GO:0002164, GO:0007275, GO:0044699, GO:0048869, GO:0042688, GO:0048513, GO:0048534, GO:0002520, GO:0032502, GO:0042386, GO:0030154, GO:0032501, GO:0009987, GO:0048731, GO:0044767, GO:0044763, GO:0030097, GO:0048542, GO:0044707, GO:0048856, GO:0002376, GO:0008150, GO:0048732
GO:0048701 [BP]embryonic cranial skeleton morphogenesisprobableGO:0048598, GO:0048562, GO:0048568, GO:0009790, GO:0048706, GO:0009653, GO:0007275, GO:0044699, GO:0048513, GO:0043009, GO:0048705, GO:0048704, GO:0009887, GO:0032501, GO:0044767, GO:0008150, GO:0044707, GO:0001501, GO:0048856, GO:0032502, GO:0009792, GO:0048731
GO:0048813 [BP]dendrite morphogenesisprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0016358, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0048731, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048812, GO:0044763
GO:2000872 [BP]positive regulation of progesterone secretionprobableGO:0051046, GO:0051047, GO:2000243, GO:2000241, GO:2000870, GO:0023051, GO:2000831, GO:2000833, GO:0010646, GO:0050789, GO:0060341, GO:0044057, GO:0032370, GO:0065007, GO:0051049, GO:0048518, GO:2000194, GO:0051050, GO:0050793, GO:0050794, GO:0046883, GO:0008150, GO:0051239, GO:0046887, GO:0032879, GO:0044060, GO:0032368, GO:2000026, GO:0048522
GO:0042487 [BP]regulation of odontogenesis of dentin-containing toothprobableGO:0022603, GO:0050793, GO:0042481, GO:0008150, GO:2000026, GO:2000027, GO:0051239, GO:0065007, GO:0050789
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0007400 [BP]neuroblast fate determinationprobableGO:0030154, GO:0007275, GO:0044699, GO:0014016, GO:0048863, GO:0048865, GO:0048867, GO:0048869, GO:0001709, GO:0008150, GO:0032502, GO:0032501, GO:0009987, GO:0014017, GO:0044763, GO:0022008, GO:0048699, GO:0045165, GO:0044707, GO:0007399, GO:0048856, GO:0048731
GO:0001889 [BP]liver developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0061008, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0070491 [MF]repressing transcription factor bindingprobableGO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0071425 [BP]hematopoietic stem cell proliferationprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0008283, GO:0048856, GO:0007275, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0030097, GO:0072089, GO:0048534, GO:0044699, GO:0002520
GO:0071336 [BP]regulation of hair follicle cell proliferationprobableGO:0042127, GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0002063 [BP]chondrocyte developmentprobableGO:0032502, GO:0051216, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0009888, GO:0061448, GO:0044767, GO:0001501, GO:0048513, GO:0044763, GO:0008150, GO:0002062, GO:0048731, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0045669 [BP]positive regulation of osteoblast differentiationprobableGO:0051094, GO:0050793, GO:0045595, GO:0050794, GO:0045597, GO:0045667, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0030278, GO:0050789, GO:0048522
GO:0035163 [BP]embryonic hemocyte differentiationprobableGO:0048568, GO:0030154, GO:0035162, GO:0009790, GO:0007275, GO:0044699, GO:0048869, GO:0048513, GO:0048534, GO:0032502, GO:0042386, GO:0032501, GO:0009987, GO:0044767, GO:0008150, GO:0030097, GO:0002520, GO:0044707, GO:0048856, GO:0044763, GO:0002376, GO:0048731
GO:0001568 [BP]blood vessel developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0044344 [BP]cellular response to fibroblast growth factor stimulusprobableGO:0071495, GO:0009719, GO:0051716, GO:0071363, GO:0050896, GO:0009987, GO:0044763, GO:0070848, GO:0071310, GO:0008150, GO:0070887, GO:0071774, GO:0042221, GO:0010033, GO:0044699
GO:0016360 [BP]sensory organ precursor cell fate determinationprobableGO:0060582, GO:0032501, GO:0060581, GO:0009653, GO:0007275, GO:0044699, GO:0007389, GO:0010160, GO:0048869, GO:0001709, GO:0048513, GO:0048645, GO:0048646, GO:0032502, GO:0009887, GO:0030154, GO:0009987, GO:0044767, GO:0008052, GO:0008150, GO:0003002, GO:0048731, GO:0045165, GO:0048859, GO:0007423, GO:0044707, GO:0048856, GO:0044763
GO:0007486 [BP]imaginal disc-derived female genitalia developmentprobableGO:0061458, GO:0032501, GO:0048608, GO:0007275, GO:0044699, GO:0000003, GO:0003006, GO:0030540, GO:0045137, GO:0048513, GO:0048806, GO:0032502, GO:0035215, GO:0007484, GO:0046545, GO:0044767, GO:0022414, GO:0008150, GO:0046660, GO:0007548, GO:0044707, GO:0007444, GO:0048856, GO:0048731
GO:0007469 [BP]antennal developmentprobableGO:0032502, GO:0044767, GO:0035214, GO:0044707, GO:0007444, GO:0032501, GO:0048856, GO:0035107, GO:0035114, GO:0048513, GO:0008150, GO:0044699, GO:0048731, GO:0009653, GO:0007275, GO:0048736, GO:0048737
GO:0032332 [BP]positive regulation of chondrocyte differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0032330, GO:0045595, GO:0061035, GO:2000026, GO:0008150, GO:0051239, GO:0048518, GO:0065007, GO:0050789, GO:0048522
GO:0019904 [MF]protein domain specific bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0002076 [BP]osteoblast developmentprobableGO:0032502, GO:0048856, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0044767, GO:0001503, GO:0044763, GO:0044699, GO:0008150, GO:0009987, GO:0001649
GO:0005524 [MF]ATP bindingprobableGO:0043168, GO:0003674, GO:0005488, GO:0030554, GO:0035639, GO:0097159, GO:1901363, GO:0043167, GO:0036094, GO:0032553, GO:0032559, GO:0001883, GO:0032549, GO:0032555, GO:0017076, GO:0000166, GO:0032550, GO:1901265, GO:0001882
GO:0045879 [BP]negative regulation of smoothened signaling pathwayprobableGO:0008589, GO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0045786 [BP]negative regulation of cell cycleprobableGO:0051726, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0046672 [BP]positive regulation of compound eye retinal cell programmed cell deathprobableGO:0051094, GO:0050793, GO:0008150, GO:0022603, GO:0045595, GO:0060284, GO:0050789, GO:0065007, GO:0010942, GO:0043067, GO:0046670, GO:0046668, GO:0046669, GO:0051239, GO:0048522, GO:0048518, GO:2000026, GO:0010941, GO:0043068, GO:0050794, GO:2000027
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0060216 [BP]definitive hemopoiesisprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0001958 [BP]endochondral ossificationprobableGO:0060350, GO:0048705, GO:0009887, GO:0036075, GO:0044707, GO:0048513, GO:0032501, GO:0048856, GO:0060349, GO:0060348, GO:0044767, GO:0001501, GO:0001503, GO:0008150, GO:0048731, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0048935 [BP]peripheral nervous system neuron developmentprobableGO:0048666, GO:0032502, GO:0048699, GO:0048856, GO:0030182, GO:0007399, GO:0007422, GO:0009987, GO:0048869, GO:0030154, GO:0048468, GO:0044767, GO:0032501, GO:0044763, GO:0008150, GO:0048934, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0044707
GO:0030217 [BP]T cell differentiationprobableGO:0030154, GO:0042110, GO:0045321, GO:0007275, GO:0044699, GO:0048869, GO:0048513, GO:0048534, GO:0032502, GO:0032501, GO:0009987, GO:0044767, GO:0001775, GO:0046649, GO:0044763, GO:0048731, GO:0002521, GO:0002520, GO:0044707, GO:0048856, GO:0030097, GO:0002376, GO:0030098, GO:0008150
GO:0002051 [BP]osteoblast fate commitmentprobableGO:0032502, GO:0045165, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0001503, GO:0044763, GO:0044699, GO:0008150, GO:0009987, GO:0001649
GO:0045766 [BP]positive regulation of angiogenesisprobableGO:0022603, GO:0050793, GO:0051094, GO:0045765, GO:0008150, GO:1901342, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0035211 [BP]spermathecum morphogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0050680 [BP]negative regulation of epithelial cell proliferationprobableGO:0042127, GO:0008285, GO:0050678, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0045467 [BP]R7 cell developmentprobableGO:0048749, GO:0044707, GO:0042051, GO:0030154, GO:0048468, GO:0045466, GO:0009653, GO:0007275, GO:0044699, GO:0042462, GO:0042461, GO:0048869, GO:0048513, GO:0048666, GO:0009887, GO:0032501, GO:0030182, GO:0048592, GO:0009987, GO:0044767, GO:0001654, GO:0048731, GO:0001754, GO:0022008, GO:0001751, GO:0001745, GO:0048699, GO:0007399, GO:0007423, GO:0048856, GO:0044763, GO:0046530, GO:0008150, GO:0032502
GO:0040036 [BP]regulation of fibroblast growth factor receptor signaling pathwayprobableGO:0090287, GO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0005667 [CC]transcription factor complexprobableGO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0043425 [MF]bHLH transcription factor bindingprobableGO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0035314 [BP]scab formationprobableGO:0032501, GO:0044707, GO:0050896, GO:0009611, GO:0042060, GO:0006950, GO:0008150, GO:0044699
GO:0048477 [BP]oogenesisprobableGO:0044702, GO:0048609, GO:0032504, GO:0019953, GO:0007292, GO:0022414, GO:0032501, GO:0008150, GO:0044699, GO:0007276, GO:0000003
GO:0035115 [BP]embryonic forelimb morphogenesisprobableGO:0048598, GO:0032502, GO:0035108, GO:0044707, GO:0030326, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0035136, GO:0044699, GO:0035113, GO:0008150, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0042675 [BP]compound eye cone cell differentiationprobableGO:0048749, GO:0032502, GO:0009887, GO:0009653, GO:0044707, GO:0007423, GO:0048869, GO:0048592, GO:0030154, GO:0044767, GO:0048513, GO:0044763, GO:0008150, GO:0048731, GO:0001654, GO:0009987, GO:0001745, GO:0032501, GO:0007275, GO:0044699, GO:0048856
GO:0042475 [BP]odontogenesis of dentin-containing toothprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0042476, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0045778 [BP]positive regulation of ossificationprobableGO:0051240, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0030278, GO:0050789
GO:0002318 [BP]myeloid progenitor cell differentiationprobableGO:0032502, GO:0002376, GO:0009987, GO:0044707, GO:0048856, GO:0048869, GO:0032501, GO:0030154, GO:0044767, GO:0002244, GO:0048513, GO:0044763, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0007419 [BP]ventral cord developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 1EAQ, chain A
Confidence level:very confident
Coverage over the Query: 27-148
View the alignment between query and template
View the model in PyMOL